首页> 美国卫生研究院文献>other >Near-Infrared Emission CuInS/ZnS Quantum Dots: All-in-One Theranostic Nanomedicines with Intrinsic Fluorescence/Photoacoustic Imaging for Tumor Phototherapy
【2h】

Near-Infrared Emission CuInS/ZnS Quantum Dots: All-in-One Theranostic Nanomedicines with Intrinsic Fluorescence/Photoacoustic Imaging for Tumor Phototherapy

机译:近红外发射CuInS / ZnS量子点:带有固有荧光/光声成像技术的肿瘤肿瘤光疗多合一纳米治疗药物。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Many theranostic nanomedicines (NMs) have been fabricated by packaging imaging and therapeutic moieties together. However, concerns about their potential architecture instability and pharmacokinetic complexity remain major obstacles to their clinical translation. Herein, we demonstrated the use of CuInS/ZnS quantum dots (ZCIS QDs) as “all-in-one” theranostic nanomedicines that possess intrinsic imaging and therapeutic capabilities within a well-defined nanostructure. ZCIS QDs were exploited for multispectral optical tomography (MSOT) imaging and synergistic PTT/PDT therapy. Due to the intrinsic fluorescence/MSOT imaging ability of the ZCIS QDs, their size-dependent distribution profiles were successfully visualized at tumor sites in vivo. Our results showed that the smaller nanomedicines (ZCIS NMs-25) have longer tumor retention times, higher tumor uptake, and deeper tumor penetration than the larger nanomedicines (ZCIS NMs-80). The ability of ZCIS QDs to mediate photoinduced tumor ablation was also explored. Our results verified that under a single 660 nm laser irradiation, the ZCIS NMs had simultaneous inherent photothermal and photodynamic effects, resulting in high therapy efficacy against tumors. In summary, the ZCIS QDs as “all-in-one” versatile nanomedicines allow high therapeutic efficacy as well as noninvasively monitoring tumor site localization profiles by imaging techniques and thus hold great potential as precision theranostic nanomedicines.
机译:通过将成像和治疗部分包装在一起,已经制造出许多治疗学纳米药物(NMs)。但是,对其潜在结构不稳定和药代动力学复杂性的担忧仍然是其临床翻译的主要障碍。在本文中,我们证明了将CuInS / ZnS量子点(ZCIS QD)用作“多合一”治疗学纳米药物,这些药物在明确定义的纳米结构内具有固有的成像和治疗功能。 ZCIS QD被用于多光谱光学层析成像(MSOT)成像和PTT / PDT协同治疗。由于ZCIS QD具有固有的荧光/ MSOT成像能力,因此可以在体内肿瘤部位成功观察到它们的大小依赖性分布图。我们的结果表明,与较大的纳米药物(ZCIS NMs-80)相比,较小的纳米药物(ZCIS NMs-25)具有更长的肿瘤保留时间,更高的肿瘤吸收率和更深的肿瘤穿透力。还探讨了ZCIS QD介导光诱导的肿瘤消融的能力。我们的结果证实,在单个660 nm激光照射下,ZCIS NMs同时具有固有的光热和光动力效应,从而对肿瘤具有很高的治疗功效。综上所述,ZCIS QD作为“多合一”多功能纳米药物具有很高的治疗功效,并且可以通过成像技术无创地监测肿瘤部位的定位情况,因此具有作为精确治疗性纳米治疗药物的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号